$LWAY

Lifeway Foods, Inc.

Insider trades

No enriched coverage for $LWAY in the last 7 days.

$5.2M
SMOLYANSKY EDWARD
0%
See all $LWAY insider activity →
Low

Lifeway Foods (LWAY) Gains from Consumer Health Trends

Riverwater Partners’ Micro Opportunities Strategy Q2 2026 investor letter said the strategy lagged the Russell Microcap Index over 12 months. It highlighted Lifeway Foods (NASDAQ:LWAY), noting record quarterly sales of $63 million, up 37%, gross margin expansion from favorable milk costs, and a plant expansion on track. LWAY closed July 23, 2026 at $30.33.

LWAY sentiment & insider activity

Recent LWAY coverage spans insider activity, financial news and sector analysis.

In the last 30 days, LWAY insiders filed 4 SEC Form 4 transactions — no purchases and 4 sales ($5.2M). The most active reporter was SMOLYANSKY EDWARD with 2 filings.

What's driving LWAY

  • The article is primarily a hedge-fund letter citing Lifeway’s recent sales growth and margin drivers, plus a capex timeline.

    insidermonkey.com · Jul 24, 2026

  • This is a routine insider sale disclosure with no stated 10b5-1 plan, but it does not by itself signal a fundamental change.

    SEC EDGAR · Jul 23, 2026

  • This is a disclosed insider sale by a large holder, but it is not accompanied by new company fundamentals or guidance.

    SEC EDGAR · Jul 16, 2026

  • The piece frames Lifeway as the dominant US kefir consolidator with accelerating sales and reiterated FY2027 adjusted EBITDA guidance, supporting a bullish fundamental read-through.

    dairyreporter.com · Jul 10, 2026

  • Insider selling by a 10% owner is a modest, sentiment-sensitive signal, but it is not a fundamental catalyst by itself.

    SEC EDGAR · Jul 9, 2026

alphai scores every news story that mentions LWAY with an AI model for sentiment and relevance, and aggregates insider trades from Lifeway Foods, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $LWAY

Score

Lifeway Foods (LWAY) Gains from Consumer Health Trends

Riverwater Partners’ Micro Opportunities Strategy Q2 2026 investor letter said the strategy lagged the Russell Microcap Index over 12 months. It highlighted Lifeway Foods (NASDAQ:LWAY), noting record quarterly sales of $63 million, up 37%, gross margin expansion from favorable milk costs, and a plant expansion on track. LWAY closed July 23, 2026 at $30.33.

Why Lifeway is central to the US kefir boom

Circana data says US kefir value grew 29.1% and volume 26.1% over the past year. Lifeway Foods holds about 85% of the US kefir market and sells kefir plus adjacent cultured dairy products. FY2025 net sales rose to $212.5m and net income to $13.9m; Q1 2026 sales were $63m (+36.7%). Lifeway targets $45m-$50m adjusted EBITDA for FY2027. Danone sold its ~23% stake for about $67m in May 2026.

Lifeway Foods, Inc. (LWAY): Entry into a Material Definitive Agreement

Lifeway Foods, Inc. (LWAY) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 lifeway_ex1001.htm MASTER SECURITY AGREEMENT, INTERIM FUNDING AGREEMENT, AND EQUIPMENT GUIDANCE LINE NOTE Exhibit 10.1 MASTER SECURITY AGREEMENT This Master Security Agreement, dated as of June 30, 2026 (as the same may from time to time be amended, restated, modified o

Related tickers